The vaccine acts by recruiting different types of cells in the tumor microenvironment, such as CD4+ and CD8+ lymphocytes, granulocytes, macrophages, and dendritic cells, which lead the tumor cells to apoptosis [8]. This evidence concerns the gene CD8A and neoplasm.